SNM Med Ltd 12193421 false 2022-10-01 2023-09-30 2023-09-30 The principal activity of the company is medical practice. Digita Accounts Production Advanced 6.30.9574.0 true true 12193421 2022-10-01 2023-09-30 12193421 2023-09-30 12193421 bus:Original 2023-09-30 12193421 core:RetainedEarningsAccumulatedLosses 2023-09-30 12193421 core:ShareCapital 2023-09-30 12193421 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 12193421 core:Non-currentFinancialInstruments core:AfterOneYear 2023-09-30 12193421 core:LandBuildings 2023-09-30 12193421 bus:SmallEntities 2022-10-01 2023-09-30 12193421 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 12193421 bus:FullAccounts 2022-10-01 2023-09-30 12193421 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 12193421 bus:RegisteredOffice 2022-10-01 2023-09-30 12193421 bus:Director1 2022-10-01 2023-09-30 12193421 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 12193421 core:LandBuildings 2022-10-01 2023-09-30 12193421 countries:UnitedKingdom 2022-10-01 2023-09-30 12193421 2022-09-30 12193421 core:LandBuildings 2022-09-30 12193421 2021-10-01 2022-09-30 12193421 2022-09-30 12193421 core:RetainedEarningsAccumulatedLosses 2022-09-30 12193421 core:ShareCapital 2022-09-30 12193421 core:CurrentFinancialInstruments core:WithinOneYear 2022-09-30 12193421 core:Non-currentFinancialInstruments core:AfterOneYear 2022-09-30 12193421 core:LandBuildings 2022-09-30 iso4217:GBP xbrli:pure

Registration number: 12193421

SNM Med Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 September 2023

 

SNM Med Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

SNM Med Ltd

Company Information

Director

Dr Sanjeev Maharaj

Registered office

7 Fairway
Poulton-le-Fylde
Lancashire
FY6 7WD

Accountants

Rawcliffe & Co Limited
Chartered accountants
Unit 1 Barons Court
Graceways
Whitehills Business Park
Blackpool
Lancashire
FY4 5GP

 

SNM Med Ltd

(Registration number: 12193421)
Abridged Balance Sheet as at 30 September 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

593,433

561,662

Current assets

 

Cash at bank and in hand

 

67,508

47,079

Creditors: Amounts falling due within one year

(492,965)

(495,664)

Net current liabilities

 

(425,457)

(448,585)

Total assets less current liabilities

 

167,976

113,077

Creditors: Amounts falling due after more than one year

(34,550)

(41,900)

Accruals and deferred income

 

(2,730)

(2,550)

Net assets

 

130,696

68,627

Capital and reserves

 

Called up share capital

6

100

100

Retained earnings

130,596

68,527

Shareholders' funds

 

130,696

68,627

For the financial year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 15 December 2023
 

.........................................
Dr Sanjeev Maharaj
Director

 

SNM Med Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2023

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
7 Fairway
Poulton-le-Fylde
Lancashire
FY6 7WD

These financial statements were authorised for issue by the director on 15 December 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

SNM Med Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2023

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

SNM Med Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2023

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

4

Tangible assets

Land and buildings
£

Total
£

Cost or valuation

At 1 October 2022

561,662

561,662

Additions

31,771

31,771

At 30 September 2023

593,433

593,433

Depreciation

Carrying amount

At 30 September 2023

593,433

593,433

At 30 September 2022

561,662

561,662

Included within the net book value of land and buildings above is £593,433 (2022 - £561,662) in respect of freehold land and buildings.
 

5

Debtors

Debtors includes £Nil (2022 - £Nil) due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary of £1 each

100

100

100

100